Actym Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Actym therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Actym Therapeutics Today - Breaking & Trending Today

Actym Raises $59.5M In Series A funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

United States , Christopher Thanos , Boehringer Ingelheim Venture Fund , Actym Therapeutics , Illumina Ventures , Panacea Ventures ,

TOLREMO therapeutics Completes USD 39 Million Series A Financing Round with Strategic Investment from Pierre Fabre Invest

TOLREMO therapeutics Completes USD 39 Million Series A Financing Round with Strategic Investment from Pierre Fabre Invest
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

San Francisco , United States , Baden Wüberg , Stanford University , Francesco Hofmann , Juliem Cherrington , Alison Opalko , Julie Cherrington , University Of Minnesota , University Of California , Trophic Communications , Mirati Therapeutics Inc , Gilead Sciences , Pierre Fabre Invest , Chief Executive Officer , Pierre Fabre Laboratories , Medical Care , Sardona Therapeutics , Kisoji Biotechnology , Actym Therapeutics , Venture Partner , Brandon Capital ,

Neurona Therapeutics Appoints James Stutz as Chief Financial Officer and Chief Business Officer

SAN FRANCISCO, July 31, 2023 (GLOBE NEWSWIRE) Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today announced the appointment of James Stutz, a business and finance executive with over 20 years of experience in the biopharma industry, as chief financial officer (CFO) and chief business officer (CBO). “We are delighted to welcome James to the Neurona team and look forward to the value he ....

United States , James Stutz , Coryr Nicholas , Alios Biopharma , Elizabeth Wolffe , Sylvia Wheeler , Janssen Pharmaceutical Companies Of Johnson , Essex Woodlands Health Ventures , Strategic Decisions Group , University Of California At Santa Barbara , United States Air , Tuck School Of Business At Dartmouth , Actym Therapeutics , Instil Bio , Janssen Pharmaceutical Companies , Revance Therapeutics , Thermo Fisher Scientific , Tuck School , Media Contacts ,